Clinical Trials Browser

Has results × Gastrointestinal Neoplasms × fosaprepitant × Clear all

NCT01504711 2021-04-08

Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy

Phase NA Completed

30 enrolled 12 charts

Gastrointestinal

Gastrointestinal Neoplasms